The Alzheimer’s Society announced that Dr. Thalia Field and the CANARY team has been awarded a grant of $100,000 over three years for the CANARY project. The Alzheimer’s Society Research Program provides funding for Canadian researchers in the field of Alzheimer’s disease and other dementias.
Clinical trials use many methods to identify people for research. These methods are resource intensive, invasive, and require expert interpretation. After going through these processes, roughly 80% who are screened are still unable to participate in a clinical trial.
Moving forward, we aim to make research participation more comfortable for those living with Alzheimer’s disease. We also want to make research more efficient so that we can develop an effective medication as soon as possible.”